Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1444, 2004-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pemetrexed + either carboplatin or oxaliplatin for advanced NSCLC
Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. :
Access to resources
Recommend
Gemcitabine plus pemetrexed promising in advanced NSCLC
Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. :
Docetaxel plus gemcitabine shows antitumour efficacy in patients with advanced NSCLC
Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. :
Paclitaxel plus cisplatin and lonidamine showed `good activity' in advanced ovarian cancer
Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. :
Gemcitabine plus cisplatin for NSCLC
Inpharma, Vol. 1, Iss. 1222, 2000-01 ,pp. :